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Genome-wide association studies have associated common varia-
tions at chromosomes 5p15 and 15q25 with lung cancer risk. The
5p15 locus has also been associated with increased bladder cancer
risk in a recent report. The 15q25 locus has been associated with
nicotine dependence and self-reported number of cigarettes
smoked per day in some studies and it was proposed that its asso-
ciation with lung cancer may be mediated through differences in
smoking behavior. Here, we investigated the roles of variations at
5p15 (rs401681, rs402710, rs2736098 and rs2736100) and 15q25
(rs1051730 and rs8034191) in bladder cancer etiology in two
case–control studies conducted separately in Los Angeles County,
CA, USA (498 cases and 588 controls) and in Shanghai, China (506
cases and 530 controls). We replicated the association between the
5p15 locus and bladder cancer among non-Hispanic whites (NHW)
in Los Angeles [for rs2736100, per C allele odds ratio (OR) 5 1.23;
95% confidence interval (CI), 1.02–1.48; P 5 0.029] and among
Chinese in Shanghai (OR 5 1.22; 95% CI, 1.02–1.47; P 5 0.033).
Both rs1051730 and rs8034191 at 15q25 were rare among Chinese.
Among NHW, a significant association was found between
rs8034191 and bladder cancer which persisted after adjustment
for cigarette smoking status, number of cigarettes smoked per
day and number of years of smoking (per C allele OR 5 1.26;
95% CI, 1.04–1.54; P 5 0.017). Our results support 5p15 and
15q25 as susceptibility regions for bladder cancer risk.
Introduction
Since 2005, numerous genome-wide association studies (GWAS) have
been reported and new susceptibility genes and pathways have been
pointed out (1). Kiemeney et al. (2) reported the first GWAS of bladder
cancer, which included subjects from various countries in Europe. The
strongest association was observed for rs9642880 located at 8q24,
which has been replicated in a Chinese study (3) and in our study in
Los Angeles County, CA, USA and Shanghai, China (4). The second
strongest association was observed for rs715021 located at 3q28, which
we also recently replicated (5) along with a Chinese study (3). In the
recently published second GWAS of bladder cancer (6), a new suscep-
tibility variant (rs2294008) on chromosome 8q24 was identified.
In addition to the single nucleotide polymorphisms (SNPs) identi-
fied by GWAS of bladder cancer, two variants in 5p15 (rs401681 and
rs2736098) have been found to be significantly associated with blad-
der cancer in a study in individuals of European ancestry, and despite
being highly correlated with each other, neither variant could fully
account for the association of the other (7). These variants are in
linkage disequilibrium (LD) with the CLPTM1L gene and the telo-
merase reverse transcriptase (TERT)gene, and both variants have also
been associated with basal cell carcinoma (7), lung cancer (8–11),
glioma (12) and other tumors (7).
Genetic variants at rs8034191 and rs1051730 in 15q25 region have
been associated with lung cancer risk (10,11,13–19), nicotine depen-
dence (14,16,20) and smoking behavior (10,14,16–19,21–24). In prior
studies, the lung cancer risk alleles at this locus have been correlated
with a higher Fagerstrom Test for Nicotine Dependence scores (14) and
a higher consumption of cigarettes (22). It is estimated that each copy of
the A allele of rs1051730 corresponds to an increase in one cigarette
smoked per day (14,22,24). These SNPs are located within an LD block
containing three nicotinic receptors: CHRNA3, CHRNA5 and
CHRNB4. Since smoking is a major risk factor for bladder cancer, it
is plausible that variation in genes that affect smoking behavior, such as
rs8034191 and rs1051730, might be associated with bladder cancer risk.
We have investigated the roles of these SNPs at 5p15 (rs401681,
rs2736098 and two additional correlated SNPs rs402710 and
rs2736100) and 15q25 (rs8034191 and rs1051730) in the risk of bladder
cancer in non-Hispanic whites (NHW) in Los Angeles County and
Chinese in Shanghai, taking into account smoking behavior and tumor
characteristics. Other SNPs in the 15q25 region, such as rs2036534,
rs667282, rs12910984 and rs6495309, which were also associated with
bladder cancer among Chinese (18), were reported after the completion
of our genotyping and therefore were not examined in the present study.
Materials and methods
Study population
Study subjects were participants in two population-based case–control studies:
one in Los Angeles County, CA, USA and the other in Shanghai, China (25). In
the Los Angeles study, case patients were Los Angeles County non-Asian
residents aged 25–64 years, diagnosed with histologically confirmed bladder
cancer between 1987 and 1996 identified through the Los Angeles County
Cancer Surveillance Program, one of the National Cancer Institute’s Surveil-
lance, Epidemiology and End Results registries. For each case, one control
subject was identified from the neighborhood of residence of the case using
a previous procedure (25) and was matched to the index case on age (±5 years),
gender and race/ethnicity (NHW, Hispanic or African–American). In
Shanghai, case patients were Shanghai Chinese residents aged 25–74 years,
diagnosed with histologically confirmed bladder cancer between 1995 and
1998 identified through the Shanghai Cancer Registry. Population-based con-
trols were randomly selected from the city of Shanghai using an algorithm
described previously (26) and were frequency matched to bladder cancer cases
by gender and 5 years age groups during the recruitment period. All individuals
were interviewed in person using a structured questionnaire that ascertained
information on demographic, lifestyle and medical characteristics up to a ref-
erence date: 2 years before cancer diagnosis for cases and 2 years before the
interview for controls (Shanghai study) or diagnosis of the index/paired case
(Los Angeles County). Clinical characteristics of the tumors were obtained
from pathology reports, which at the time of this study were only available for
cases identified in Los Angeles County. Consistent with Kiemeney et al. (2),
tumors with tumor-node-metastasis stage pTa and grade 1 or 2 were classified
as having a low risk of progression and the rest as having a high risk of pro-
gression. Additional details from both studies can be found in the supplemen-
tary Materials and Methods, available at Carcinogenesis Online.
Samples of peripheral blood were requested from participants in the
Shanghai study and from participants in the Los Angeles County component
who were interviewed from January 1992 on. In Los Angeles, 74% of cases and
79% of controls who were asked to donate a blood sample consented, among
whom, 79% of cases and 86% of controls had enough DNA materials for the
Abbreviations: CI, confidence interval; GWAS, genome-wide association
studies; LD, linkage disequilibrium; NHW, non-Hispanic whites; OR, odds
ratio; SNPs, single nucleotide polymorphisms.
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current genotyping effort. The corresponding figures in Shanghai were 89, 89,
98 and 99%. We have found no differences with respect to the distribution of
demographic characteristics, including age, sex, level of education and ciga-
rette smoking between those who were genotyped and the original study par-
ticipants for both Los Angeles and Shanghai. All blood components (plasma,
serum, buffy coat and red cells) were stored at 80C until analysis. The
majority of Los Angeles participants with DNA were NHW (88% cases and
89% of controls) and all participants in Shanghai were Han Chinese. Given
these distributions, this report was restricted to NHW and Chinese participants
with questionnaire data and DNA samples. Thus, this analysis includes 498
cases and 588 controls from Los Angeles and 506 cases and 530 controls from
Shanghai.
Permissions to conduct the study were obtained from the Institutional Review
Boards at the University of Southern California, the University of Minnesota and
the Shanghai Cancer Institute. Informed consent forms for interview and bio-
specimen collection were obtained from each study participant.
Genotyping
DNA was extracted from peripheral blood lymphocytes using proteinase K
digestion followed by phenol–chloroform extraction and ethanol precipitation
as described previously (27). DNA samples from the Los Angeles County
subjects were whole genome amplified using a REPLI-g mini kit from Qiagen
(Valencia, CA). Genotyping of rs401681, rs402710, rs2736098, rs2736100,
rs1051730 and rs8034191 was performed using Taqman assays from Applied
Biosystems (Foster City, CA). An ABI 7900HT Sequence Detection and Scor-
ing System was used for allele scoring. For quality control, 5% randomly
selected samples were duplicated and all duplicates except one were matched
for all six SNPs. The overall call rate was .96%.
Statistical analysis
For each SNP, genotypic frequencies among NHW and Chinese controls were
examined separately for deviations from Hardy–Weinberg Equilibrium using
exact tests. No deviations were observed among NHW controls. Among
Chinese controls, statistically significant increased numbers of heterozygous
genotypes of rs2736098 (270 observed versus 242 expected under Hardy–
Weinberg Equilibrium; P 5 0.009) were observed. The genotyping data of
this SNP showed clear genotype separation with call rates .98% and concor-
dance rates of 100% among replicates. Therefore, it is unlikely that we have
genotyping errors. Population stratification is unlikely to explain the above
deviations, considering the homogeneity of the study population in Shanghai.
NHW cases and controls with available data on genotypes were not all
individually matched due to differential donation of blood samples within each
matching pair. To maximize the sample size and match the analyses between
NHW and Chinese, we created a composite variable that classified subjects
according to their reference age (,45, 45–49, 50–54, 55–59 and 60 years for
NHW and ,45, 45–49, 50–54, 55–59, 60–64 and 65 years for Chinese),
gender and study site (Los Angeles or Shanghai) and used it to stratify subjects
in conditional logistic regression models. Results were not materially changed
when unconditional logistic regression was used with additional adjustment for
age (continuous), gender and race. We further adjusted for smoking status in
reference year, number of cigarettes smoked per day (when smoking) and
number of years of smoking. Relative risks were estimated by odds ratios
(ORs); per allele ORs and 95% (CIs) were estimated for those carrying the
high-risk allele relative to those carrying the homozygous low-risk allele at
each locus assuming a log-additive mode of risk. To account for the multiple
correlated tests due to LD between markers in a single region, we adjusted the
final reported P-value using the PACT approach (28). This procedure yielded
a region-level adjusted P-value (Padj) for each SNP. PACT analyses were per-
formed using the statistical package R 2.11.1 (29).
We tested for interaction between genotypes and other risk factors, including
smoking status in reference year, number of cigarettes smoked per day, number
of years of smoking, pack years of smoking, age, gender and race, on a mul-
tiplicative scale. Likelihood ratio tests were used to test the interaction assum-
ing a log-additive mode of risk for the high-risk allele. For interaction analyses
with age, age was tested as a continuous variable as well as a two-category
variable dichotomized at the median age of the controls at reference date: 56
for NHW and 64 for Chinese. Among Los Angeles County participants, the
SNP-bladder cancer associations were also estimated within tumors with dif-
ferent risks of progression (low or high) using conditional logistic regression
models as described above. Heterogeneity between ORs for tumors with dif-
ferent risks of progression was assessed using logistic regression analyses re-
stricted to cases (case-only analyses) with the tumor characteristic as the
outcome variable. LD measures were calculated using the PROC ALLELE
procedure from SAS (SAS Institute, Cary, NC).
All statistical tests (P values) were two sided and all analyses were con-
ducted using SAS statistical software version 9.2 (SAS Institute).
Results
Characteristics of the two study populations have been previously
reported (5). Briefly, in both Los Angeles and Shanghai, the majority
(80%) of the study participants was male (Table I). The mean age at
enrollment was 54 and 61 years for our Los Angeles and Shanghai
participants, respectively. A much higher level of education was ob-
served in Los Angeles participants with 67% of cases and 77% of
controls having had college or higher education. The corresponding
figures for Shanghai were 21 and 22%. A higher rate of cigarette
smoking was reported in Los Angeles than in Shanghai (81% of cases
and 61% of controls in Los Angeles versus 65 and 55% in Shanghai);
however, smokers in Shanghai were more probably to be current
smokers and long-term smokers.
The frequencies of alleles of each SNP in controls in our study were
similar to data from previously published studies on NHW (7,14,15)
and Chinese (18,30) and to the HapMap database (31). Key findings of
the associations between SNPs at chromosomes 5p15 and 15q25 and
bladder cancer risk are summarized in Tables II and III, respectively.
5p15 SNPs (rs401681, rs402710, rs2736098 and rs2736100) and
bladder cancer risk
The correlations between the four 5p15 SNPs in our study were similar
to data from the HapMap (31). Specifically, the pair-wise correlation
(R2) between rs402710 and rs401681 was 0.52 among NHW controls
and 0.94 among Chinese controls, and all the other pair-wise R2 were
,0.300. All four SNPs showed association with bladder cancer risk in
both populations (Table II), although among NHW, only rs2736100
reached statistical significance (per C allele OR 5 1.23; 95% CI 1.02–
1.48). Among Chinese, associations of similar magnitude were ob-
served for all four SNPs, and the associations were statistically sig-
nificant for all four. The OR per C allele of rs2736100 was 1.22 (95%
CI, 1.02–1.47). The strongest association was found for rs2736098
among Chinese (P 50.019; Padj 5 0.059). We also examined the
joint effect of SNPs within the 5p15 region (data not shown; haplotype
results are in supplementary Table 1). After adjustment for rs2736100,
only the association of rs402710 among Chinese remained significant.
There was no significant heterogeneity of risk estimates between
NHW and Chinese in any of the analyses.
The associations between rs2736100 and bladder cancer were
slightly more pronounced among individuals younger than the median
age than among older individuals (supplementary Table 2 is available
at Carcinogenesis Online). The per allele OR of rs2736100 was 1.30
(95% CI, 0.99–1.69) among NHW ,56 years and 1.38 (95% CI,
1.06–1.81) among Chinese ,64 years, whereas the corresponding
figures among older subjects were 1.15 (95% CI, 0.89–1.49) and
1.11 (95% CI, 0.85–1.44), respectively. However, the differences by
age were only marginally significant in NHW (P for interaction with
age 5 0.069, 0.17 and 0.064 for NHW, Chinese and both races com-
bined, respectively). When stratified by smoking variables, among
NHW, the association between rs2736100 and bladder cancer risk
was stronger in current than in never or former smokers (Table II),
and this difference was more pronounced among those in the higher
category of smoking (data not shown). However, similar differences
were not observed among Chinese. No consistent pattern was ob-
served in the rs2736100–bladder cancer association by number of
cigarettes smoked per day, number of years of smoking or pack years
of smoking. Among NHW, we also investigated potential heteroge-
neity of the rs2736100–bladder cancer association across tumors with
different risk of progression (Table IV). The per allele ORs of
rs2736100 were 1.30 (1.04–1.62) and 1.15 (0.90–1.47) for tumors
with low and high risk of progression, respectively (P for heteroge-
neity 5 0.47).
15q25 SNPs (rs1051730 and rs8034191) and bladder cancer risk
The A allele of rs1051730 and the C allele of rs8034191 were rare
(,5%) among Chinese, as previously noted (18). Among NHW,
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association between rs1051730 and bladder cancer risk was of bor-
derline statistical significance (Table III; per A allele OR 5 1.19; 95%
CI, 0.98–1.45). A statistically significant association between
rs8034191 and risk of bladder cancer was observed (per C allele
OR 5 1.26; 95% CI, 1.04–1.54; P 5 0.017; Padj 5 0.025). Adjust-
ment for cigarette smoking status, number of cigarettes smoked per
day and number of years of smoking did not seem to affect the above
associations. When stratified by smoking variables, the rs8034191–
bladder cancer association appeared to be stronger among former
smokers (Table III; per C allele OR 5 1.44; 95% CI, 1.06–1.95),
particularly among those in the highest smoking categories (data
not shown). The rs8034191–bladder cancer association was similar
for tumors with low and high risk of progression (Table IV).
Given the important role of smoking in bladder cancer and the
previous findings of rs8034191’s association with nicotine addiction
and smoking intensity (14,16,20,21), we also investigated the associ-
ation between rs8034191 and cigarette smoking behavior among
NHW in our study (supplementary Table 3 is available at Carcino-
genesis Online). The overall evidence did not appear to support an
association between SNP rs8034191 and cigarette smoking. The fre-
quency of the C allele varied only slightly by smoking status. Among
case patients, high-risk genotypes (CT/CC) were associated with
a greater number of cigarettes smoked per day (P trend 5 0.093).
Similar trends were not observed among controls.
Discussion
The present study confirmed that rs2736100 at 5p15 region is a poten-
tial susceptibility marker of bladder cancer in both NHW and Chinese,
providing the first evidence of an association in an Asian population.
In addition, to our knowledge, we are the first to report an association
between the 15q25 region, recently identified through GWAS as a sus-
ceptibility locus for both lung cancer and smoking behavior and blad-
der cancer risk among NHW.
5p15 SNPs and bladder cancer
The SNPs rs401681, rs402710, rs2736098 and rs2736100 are located
on chromosome 5p15 with the first two SNPs residing within the
CLPTM1L gene and the latter two SNPs within the TERT gene. Var-
ious mechanisms have been proposed to explain the observed associ-
ations between this locus at 5p15 and cancer risk. One candidate is the
TERT gene, which is essential for telomere maintenance and cell
immortalization. Shorter telomeres have been associated with an in-
creased risk of bladder cancer (32,33). Rafnar et al. (7) reported that
the risk alleles of rs401681 and rs2736098 were significantly associ-
ated with shorter telomeres in older women but not in younger
women, leading the authors to hypothesize that the effect of these
variants may only become apparent after a certain age. If these
5p15 SNPs indeed increase bladder cancer risk through their associ-
ations with shorter telomeres, one would expect the associations be-
tween these SNPs and bladder cancer to be more pronounced among
older individuals. However, in our study, the 5p15 SNPs–bladder
cancer associations were slightly more pronounced among younger
individuals, although the differences were not statistically significant.
Another potential candidate causal gene for the 5p15 region is the
CLPTM1L gene, which has been reported to be involved in cellular
response to genotoxic stress and cisplatin resistance (34). In a recent
study, the risk allele of rs402710, which localizes within the
CLPTM1L gene, was associated with statistically significantly higher
levels of bulky aromatic/hydrophobic DNA adducts (formed by poly-
cyclic aromatic hydrocarbons and aldehydes found in cigarette
smoke) in adjacent normal lung tissues of lung cancer patients (35).
Table I. Characteristics of NHW in Los Angeles County and Chinese in Shanghai, China
Los Angeles County Shanghai
Cases (n 5 498) Controls (n 5 588) Cases (n 5 506) Controls (n 5 530)
Age at enrollment
45 years 52 (10%) 73 (12%) 50 (10%) 44 (8%)
45–49 years 57 (11%) 69 (12%) 29 (6%) 17 (3%)
50–54 years 92 (18%) 108 (18%) 36 (7%) 27 (5%)
55–59 years 149 (30%) 165 (28%) 40 (8%) 64 (12%)
60–64 years 148 (30%) 133 (23%) 135 (27%) 120 (23%)
65 years — 40 (7%) 216 (43%) 258 (49%)
Mean (years) 54.5 54.4 60.7 61.7
Male 396 (80%) 475 (81%) 397 (78%) 407 (77%)
Level of education
High school or below 166 (33%) 137 (23%) — —
1–3 years of college 164 (33%) 180 (31%) — —
College graduate 168 (34%) 271 (46%) — —
Elementary or below — — 167 (33%) 174 (33%)
Middle–high school — — 235 (46%) 242 (46%)
.High school — — 104 (21%) 114 (22%)
Cigarette smoking status
Never smokers 93 (19%) 228 (39%) 175 (35%) 237 (45%)
Former smokers 189 (38%) 256 (44%) 64 (13%) 84 (16%)
Current smokers 216 (43%) 104 (18%) 267 (53%) 209 (39%)
Among all smokers
,20 Cigarettes/day 82 (16%) 106 (18%) 152 (30%) 156 (29%)
20 Cigarettes/day 323 (65%) 254 (43%) 179 (35%) 137 (26%)
,30 Years of smoking 181 (36%) 235 (40%) 105 (21%) 112 (21%)
30 Years of smoking 224 (45%) 125 (21%) 226 (45%) 181 (34%)
,22.5 Pack years of smoking 117 (23%) 173 (29%) 139 (27%) 135 (25%)
22.5 Pack years of smoking 288 (58%) 187 (32%) 192 (38%) 158 (30%)
Probability of progressiona
Low: Ta/G1–2 281 (56%) — — —
High: all other stages/grades 214 (43%) — — —
Unknown 3 (1%) — — —
aAs defined by Kiemeney et al. 2008 (2).
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Similarly, in our study, among bladder cancer patients who were
smokers, rs402710 was associated with a marginally significantly
higher level of hemoglobin adducts of 4-aminobyphenyl (P 5
0.075, data not shown), a known human bladder carcinogen present
in cigarette smoke, although a similar trend was not observed among
controls (data not shown). In addition, if genetic variants in this region
affect the level of accumulated carcinogen adducts, we would expect
to observe stronger associations for SNPs in this region among sub-
jects with higher exposure to carcinogens, such as smokers. Consis-
tent with this notion, in our study, the rs2736100–bladder cancer
association among NHW appeared to be stronger in current smokers,
particularly among those in the higher category of smoking. However,
no differences by smoking status were found among Chinese, which is
consistent with findings from Rafnar et al. (7), who reported similar
associations between 5p15 SNPs and bladder cancer risk among both
smokers and nonsmokers. Thus, it is possible that the heterogeneity
Table III. SNPs at 15q25 region and bladder cancer risk among NHW
Cases/controls Crude Adjusted for smoking status in reference year, number
of cigarettes smoked and number of years of smoking
OR (95% CI)a Pa OR (95% CI)a Pa
rs1051730
GG 182/244 1.00 (ref) 1.00 (ref)
GA 231/262 1.17 (0.90–1.52) 0.23 1.17 (0.88–1.54) 0.28
AA 65/63 1.40 (0.94–2.09) 0.093 1.45 (0.96–2.20) 0.081
Per A allele 1.18 (0.99–1.42) 0.072 1.19 (0.98–1.45) 0.072
rs8034191
TT 176/248 1.00 (ref) 1.00 (ref)
CT 234/259 1.25 (0.96–1.63) 0.090 1.27 (0.96–1.68) 0.088
CC 66/61 1.54 (1.04–2.30) 0.033 1.59 (1.04–2.42) 0.031
Per C allele 1.25 (1.04–1.50) 0.019 1.26 (1.04–1.54) 0.017
Per C allele of rs8034191 stratified by smoking status
Never-smokers 56/116b 1.22 (0.85–1.75) 0.29 1.22 (0.85–1.75) 0.29
Former smokers 120/148b 1.44 (1.06–1.95) 0.018 1.44 (1.06–1.95) 0.020
Current smokers 124/56b 1.15 (0.81–1.63) 0.45 1.08 (0.76–1.55) 0.66
P for interaction between rs8034191 and smoking statusc 0.58 0.56
aResults were estimated from conditional logistic regression.
bNumber of cases and controls carrying at least one C allele at rs8034191.
cLikelihood ratio test of the interaction term between rs8034191 and three-category smoking status variable assuming a log-additive mode of risk for the C allele.
Table II. SNPs at 5p15 region and bladder cancer risk among NHW in Los Angeles County and Chinese in Shanghai
NHW Chinese
Cases/controls OR (95% CI)a Pa Cases/controls OR (95% CI)a Pa
rs401681
TT 73/106 1.00 (ref) 45/66 1.00 (ref)
CT 235/278 1.23 (0.85–1.76) 0.27 207/226 1.28 (0.83–1.97) 0.27
CC 164/170 1.36 (0.93–2.01) 0.12 248/237 1.53 (1.00–2.35) 0.052
Per C allele 1.16 (0.96–1.40) 0.13 1.22 (1.01–1.48) 0.036
rs402710
TT 42/51 1.00 (ref) 46/65 1.00 (ref)
CT 169/201 1.04 (0.64–1.69) 0.87 197/222 1.21 (0.79–1.87) 0.38
CC 260/276 1.21 (0.76–1.93) 0.43 260/240 1.53 (1.00–2.35) 0.049
Per C allele 1.12 (0.92–1.37) 0.26 1.25 (1.03–1.51) 0.021
rs2736098
CC 217/278 1.00 (ref) 178/203 1.00 (ref)
CT 189/210 1.17 (0.89–1.55) 0.27 236/270 1.00 (0.76–1.32) 0.99
TT 43/43 1.33 (0.82–2.17) 0.25 85/54 1.84 (1.23–2.77) 0.003
Per T allele 1.16 (0.94–1.43) 0.16 1.25 (1.04–1.51) 0.019
rs2736100
AA 86/127 1.00 (ref) 141/174 1.00 (ref)
AC 239/262 1.41 (1.00–1.98) 0.053 260/274 1.12 (0.84–1.49) 0.44
CC 146/158 1.55 (1.06–2.26) 0.022 98/77 1.54 (1.06–2.26) 0.025
Per C allele 1.23 (1.02–1.48) 0.029 1.22 (1.02–1.47) 0.033
Per C allele of rs2736100 stratified by smoking status
Never-smokers 73/156b 1.29 (0.91–1.83) 0.15 118/159b 1.22 (0.91–1.63) 0.18
Former smokers 147/197b 0.94 (0.71–1.25) 0.67 46/51b 1.24 (0.75–2.03) 0.40
Current smokers 165/67b 1.71 (1.19–2.45) 0.004 194/141b 1.17 (0.88–1.55) 0.29
P for interaction between rs2736100 and smoking statusc 0.038 0.89
aResults were estimated from conditional logistic regression with adjustment for smoking status in reference year, number of cigarettes smoked per day and number
of years of smoking.
bNumber of cases and controls carrying at least one C allele at rs2736100.
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by cigarette smoking that we have observed in this study may be due
to chance alone.
15q25 SNPs and bladder cancer
Two studies have assessed the associations between 15q25 SNPs and
bladder cancer risk. Kiemeney et al. (2) did not find a significant
association between rs1051730 and bladder cancer risk (combined
OR 5 1.03, P 5 0.26). In a case–control analysis by Spitz et al.
(16) that included bladder and renal cancers combined, no significant
association was found with rs1051730 (for GA genotype, OR 5 1.15,
95% CI 5 0.91–1.45; for AA genotype, OR 5 0.87, 95% CI 5 0.69–
1.26). In our study, rs8034191, which is highly correlated with
rs1051730, was associated with bladder cancer among NHW (per C
allele, OR 5 1.26; 95% CI, 1.04–1.54). We did not find comparable
associations among Chinese, but this could not be properly evaluated
given the low prevalence of the minor allele in this population. How-
ever, other SNPs in this same region, such as rs2036534, rs667282,
rs12910984 and rs6495309, have been previously reported to be as-
sociated with bladder cancer among Chinese by Wu et al. (18), sug-
gesting that a causal variant in this region might also contribute to
susceptibility to bladder cancer among this ethnic group. SNP
rs16969968, another GWAS-identified variant at 15q25, was not ex-
amined in our study because of its high LD with rs8034191 and
rs1051730, which exhibited stronger disease associations in the ear-
lier GWAS of lung cancer (13–15).
SNPs rs1051730 and rs8034191 map to a region of strong LD on
chromosome 15q25, containing CHRNB4, CHRNA3, CHRNA5,
PSMA4, IREB2 and LOC123688 (10,13). The most promising candi-
dates for a casual gene/s in this region are CHRNB4, CHRNA3 and
CHRNA5. These three genes encode the nicotinic acetylcholine re-
ceptor subunits, which play important roles in the development of
nicotine dependence. Genetic variants on 15q25 have also been asso-
ciated with nicotine dependence (14,16) and smoking behavior
(10,14,16,18,19), and adjustment for smoking reduced the 15q25
SNP-associated lung risk in some studies (14,19). However, it is still
under debate whether this locus affects lung cancer directly or the
association is mediated primarily by affecting smoking behavior
(10,13–19,36,37). In a recent study, smokers who carry the high bladder
cancer risk allele (allele A) in CHRNA3 (rs1051730) were found to
have higher levels of nicotine per cigarette dose and of urinary metab-
olites of 4-(methylnitrosamino)-I-(3-pyridyl)-1-butanone, a tobacco-
specific nitrosamine carcinogenic to humans (36). We found no
evidence or very limited evidence of an association between
rs8034191 and a greater number of cigarettes smoked per day
among bladder cancer patients; furthermore, such association was
not consistently observed among control subjects. Additionally,
adjustment for cigarette smoking did not materially change the
rs8034191–bladder cancer association in our study and there was
also little evidence of a gene  smoking interaction, suggesting that
this locus may affect bladder cancer also through other mecha-
nisms, in addition to its potential impact on smoking behavior.
In conclusion, we report that SNPs in the 5p15 and 15q25 regions
appear to play important roles in bladder cancer development. The
power of our study is limited due to the modest sample size, partic-
ularly in subgroup analyses stratified by cigarette smoking and age,
increasing thus the likelihood of spurious associations and precluding
firm conclusions. Further investigations to validate our findings and
fine map these regions to identify the functional variants are needed.
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